Lawstreet Journal

Bharat Biotech and Serum Institute of India oppose revelation of Vaccine Trail Data. ‘It is where it should be’- Counsel for Bharat Biotech

Lawstreet Journal 24 Mar 2022 2:43am

Image courtesy: Lawstreet Journal Business Bharat Biotech and Serum Institute of India oppose revelation of Vaccine Trail Data. ‘It is where it should be’- Counsel for Bharat Biotech

Vaccine manufactures Bharat Biotech Ltd and Serum Institute of India opposed the writ petition filed by Dr.Jacob Puliyel , a former member of the National Technical Advisory Group on Immunisation, seeking the data of clinical trial and adverse effects of COVID vaccines and challenging the vaccine mandates imposed by some States. Counsel for petitioner Advocate Prashant Bhushan argued that Phase III Trial of the vaccine has not been published.

Senior Advocate Guru Krishnakumar, appearing for Bharat Biotech, submitted that Covaxin was indigenously developed in association with the Indian Council for Medical Research, and it was published in Lancent medical journal in November 2021. It was further held that as per the WHO guidelines, it is not a mandate to disclosure the primary data. As per Section 8(1) (d) of the Right to Information Act, 2005, which exempts the disclosure of information including commercial confidence, trade secrets or intellectual property.

In support of Bharat Bio tech the argued that "As a matter of principle, they cannot ask for data. My data is with the regulator. That is where it should be. There is no locus for them (petitioner). Even under the RTI they have to show there is public interest. But, here, as Mr. Krishna Kumar said, it is in the contrary. My submission is that it is an infructuous petition", 

Before the arguments of the vaccine companies, the States of Tamil Nadu, Maharashtra and Madhya Pradesh defended the vaccine mandates issued by them. 

Opposing the above contention for vaccine trial data, Prashant Bhushan argued in Supreme… Continue Reading...

Tagged: Corona Updates   Serum Institute of India   Bharat Biotech  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0

C2RMTo Know More

Something Awesome Is In The Work









Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.

SAARTHTo Know More

Launching Soon : SAARTH, your complete client, case, practise & document management SAAS application with direct client chat feature.

If you want to know more give us a Call at :+91 98109 29455 or Mail